Cargando…

Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study

BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as an urgent public health threat. Intestinal colonization with CRE has been identified as a risk factor for the development of systemic CRE infection, but has not been compared to colonization with third and/or fourth generation...

Descripción completa

Detalles Bibliográficos
Autores principales: McConville, Thomas Howe, Sullivan, Sean Berger, Gomez-Simmonds, Angela, Whittier, Susan, Uhlemann, Anne-Catrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638409/
https://www.ncbi.nlm.nih.gov/pubmed/29023567
http://dx.doi.org/10.1371/journal.pone.0186195
_version_ 1783270732965347328
author McConville, Thomas Howe
Sullivan, Sean Berger
Gomez-Simmonds, Angela
Whittier, Susan
Uhlemann, Anne-Catrin
author_facet McConville, Thomas Howe
Sullivan, Sean Berger
Gomez-Simmonds, Angela
Whittier, Susan
Uhlemann, Anne-Catrin
author_sort McConville, Thomas Howe
collection PubMed
description BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as an urgent public health threat. Intestinal colonization with CRE has been identified as a risk factor for the development of systemic CRE infection, but has not been compared to colonization with third and/or fourth generation cephalosporin-resistant (Ceph-R) Enterobacteriaceae. Moreover, the risk conferred by colonization on adverse outcomes is less clear, particularly in critically ill patients admitted to the intensive care unit (ICU). METHODS: We carried out a cohort study of consecutive adult patients screened for rectal colonization with CRE or Ceph-R upon ICU entry between April and July 2013. We identified clinical variables and assessed the relationship between CRE or Ceph-R colonization and subsequent systemic CRE infection within 30 days (primary outcome) and all-cause mortality within 90 days (secondary outcome). RESULTS: Among 338 ICU patients, 94 (28%) were colonized with either Ceph-R or CRE. 26 patients developed CRE infection within 30 days of swab collection; 47% (N = 17/36) of CRE-colonized and 3% (N = 2/58) of Ceph-R colonized patients. 36% (N = 13/36) of CRE-colonized patients died within 90 days compared to 31% (N = 18/58) of Ceph-R-colonized and 15% (N = 37/244) of non-colonized patients. In a multivariable analysis, CRE colonization independently predicted development of a systemic CRE infection at 30 days (aOR 10.8, 95% CI2.8–41.9, p = 0.0006); Ceph-R colonization did not (aOR 0.5, 95% CI0.1–3.3, p = 0.5). CRE colonization was associated with increased 90-day mortality in a univariable analysis (p-value 0.001), in a multivariable model, previous hospitalization and medical ICU admission were independent predictors of 90-day mortality whereas CRE colonization approached significance (aOR 2.3, 95% CI1.0–5.3, p = 0.056). CONCLUSIONS: Our study highlights the increased risk of CRE infection and mortality in patients with CRE colonization at the time of ICU admission. Future studies are needed to assess how CRE colonization can guide empiric antibiotic choices and to develop novel decolonization strategies.
format Online
Article
Text
id pubmed-5638409
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56384092017-10-20 Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study McConville, Thomas Howe Sullivan, Sean Berger Gomez-Simmonds, Angela Whittier, Susan Uhlemann, Anne-Catrin PLoS One Research Article BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as an urgent public health threat. Intestinal colonization with CRE has been identified as a risk factor for the development of systemic CRE infection, but has not been compared to colonization with third and/or fourth generation cephalosporin-resistant (Ceph-R) Enterobacteriaceae. Moreover, the risk conferred by colonization on adverse outcomes is less clear, particularly in critically ill patients admitted to the intensive care unit (ICU). METHODS: We carried out a cohort study of consecutive adult patients screened for rectal colonization with CRE or Ceph-R upon ICU entry between April and July 2013. We identified clinical variables and assessed the relationship between CRE or Ceph-R colonization and subsequent systemic CRE infection within 30 days (primary outcome) and all-cause mortality within 90 days (secondary outcome). RESULTS: Among 338 ICU patients, 94 (28%) were colonized with either Ceph-R or CRE. 26 patients developed CRE infection within 30 days of swab collection; 47% (N = 17/36) of CRE-colonized and 3% (N = 2/58) of Ceph-R colonized patients. 36% (N = 13/36) of CRE-colonized patients died within 90 days compared to 31% (N = 18/58) of Ceph-R-colonized and 15% (N = 37/244) of non-colonized patients. In a multivariable analysis, CRE colonization independently predicted development of a systemic CRE infection at 30 days (aOR 10.8, 95% CI2.8–41.9, p = 0.0006); Ceph-R colonization did not (aOR 0.5, 95% CI0.1–3.3, p = 0.5). CRE colonization was associated with increased 90-day mortality in a univariable analysis (p-value 0.001), in a multivariable model, previous hospitalization and medical ICU admission were independent predictors of 90-day mortality whereas CRE colonization approached significance (aOR 2.3, 95% CI1.0–5.3, p = 0.056). CONCLUSIONS: Our study highlights the increased risk of CRE infection and mortality in patients with CRE colonization at the time of ICU admission. Future studies are needed to assess how CRE colonization can guide empiric antibiotic choices and to develop novel decolonization strategies. Public Library of Science 2017-10-12 /pmc/articles/PMC5638409/ /pubmed/29023567 http://dx.doi.org/10.1371/journal.pone.0186195 Text en © 2017 McConville et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
McConville, Thomas Howe
Sullivan, Sean Berger
Gomez-Simmonds, Angela
Whittier, Susan
Uhlemann, Anne-Catrin
Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study
title Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study
title_full Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study
title_fullStr Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study
title_full_unstemmed Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study
title_short Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study
title_sort carbapenem-resistant enterobacteriaceae colonization (cre) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638409/
https://www.ncbi.nlm.nih.gov/pubmed/29023567
http://dx.doi.org/10.1371/journal.pone.0186195
work_keys_str_mv AT mcconvillethomashowe carbapenemresistantenterobacteriaceaecolonizationcreandsubsequentriskofinfectionand90daymortalityincriticallyillpatientsanobservationalstudy
AT sullivanseanberger carbapenemresistantenterobacteriaceaecolonizationcreandsubsequentriskofinfectionand90daymortalityincriticallyillpatientsanobservationalstudy
AT gomezsimmondsangela carbapenemresistantenterobacteriaceaecolonizationcreandsubsequentriskofinfectionand90daymortalityincriticallyillpatientsanobservationalstudy
AT whittiersusan carbapenemresistantenterobacteriaceaecolonizationcreandsubsequentriskofinfectionand90daymortalityincriticallyillpatientsanobservationalstudy
AT uhlemannannecatrin carbapenemresistantenterobacteriaceaecolonizationcreandsubsequentriskofinfectionand90daymortalityincriticallyillpatientsanobservationalstudy